Evidence map›Paper›PMID 38875689›Full record

ArticleJMIR biomedical engineering2022

Democratizing Global Health Care Through Scalable Emergent (Beyond the Mobile) Wireless Technologies.

Graham B Jones, Andrew Bryant, Justin Wright

Abstract read
In one paragraph

Article in JMIR biomedical engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Graham B JonesTechnical Research and Development, Novartis Pharmaceuticals, East Hanover, NJ, United States.ORCID https://orcid.org/0000-0003-2195-3567
Andrew BryantTechnical Research and Development, Novartis AG, Basel, Switzerland.ORCID https://orcid.org/0000-0003-2155-7898
Justin WrightGlobal Drug Development Connected Health, Novartis Pharmaceuticals, East Hanover, NJ, United States.ORCID https://orcid.org/0000-0001-6076-0771

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances in mobile phone technologies coupled with the availability of modern wireless networks are beginning to have a marked impact on digital health through the growing array of apps and connected devices. That said, limited deployment outside of developed nations will require additional approaches to collectively reach the 8 billion people on earth. Another consideration for development of digital health centered around mobile devices lies in the need for pairing steps, firmware updates, and a variety of user inputs, which can increase friction for the patient. An alternate, so-called Beyond the Mobile approach where medicaments, devices, and health services communicate directly to the cloud offers an attractive means to expand and fully realize our connected health utopia. In addition to offering highly personalized experiences, such approaches could address cost, security, and convenience concerns associated with smartphone-based systems, translating to improved engagement and adherence rates among patients. Furthermore, connecting these Internet of Medical Things instruments through next-generation networks offers the potential to reach patients with acute needs in nonurban regions of developing nations. Herein, we outline how deployment of Beyond the Mobile technologies through low-power wide-area networks could offer a scalable means to democratize digital health and contribute to improved patient outcomes globally.

Indexed as

cloud-basedconveniencecostglobal healthInternet of ThingsIoTLPWANmHealthmobile technologypersonalizationsecuritywirelesswireless communication

Identifiers

PMID38875689
PMCPMC11041427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.